HEPATITIS MONTHLY, vol.13, no.4, 2013 (Peer-Reviewed Journal)
Article / Article
Science Citation Index Expanded, Scopus
Hepatitis C, Data Collection, P Glycoprotein, HUMAN HEPATOCELLULAR-CARCINOMA, MULTIDRUG-RESISTANCE, CLINICAL-OUTCOMES, CANCER CELLS, EXPRESSION, GENOTYPE, ALPHA, DRUG, CHEMOTHERAPY, INFECTION
Background: To treat viral infection of chronic hepatitis C (CHC) is a main strategy to prevent progression of liver disease, and cancer. Some patients with CHC have failed to respond to the common antiviral therapy in different populations.